pharmaceuticals-and-healthcare

United States Veterinary Anti-infectives Market Report 2017


Published On : Apr 2017

Category : Pharmaceutical

No. of Pages : 97 pages

  • $3800
  • $7600

SPECIFY YOUR RESEARCH NEED

  • Query Type :
  •  
Table of Contents

United States Veterinary Anti-infectives Market Report 2017
1 Veterinary Anti-infectives Overview
1.1 Product Overview and Scope of Veterinary Anti-infectives
1.2 Classification of Veterinary Anti-infectives by Product Category
1.2.1 United States Veterinary Anti-infectives Market Size (Sales Volume) Comparison by Type (2012-2022)
1.2.2 United States Veterinary Anti-infectives Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 Marbofloxacin
1.2.4 Florfenicol
1.2.5 Freeze-dried Ceftiofur
1.2.6 Beta-lactams
1.2.7 Oxytetracycline
1.2.8 Aminosidine
1.3 United States Veterinary Anti-infectives Market by Application/End Users
1.3.1 United States Veterinary Anti-infectives Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
1.3.2 Companion Animals
1.3.3 Farm Animals
1.3.4 Others
1.4 United States Veterinary Anti-infectives Market by Region
1.4.1 United States Veterinary Anti-infectives Market Size (Value) Comparison by Region (2012-2022)
1.4.2 The West Veterinary Anti-infectives Status and Prospect (2012-2022)
1.4.3 Southwest Veterinary Anti-infectives Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic Veterinary Anti-infectives Status and Prospect (2012-2022)
1.4.5 New England Veterinary Anti-infectives Status and Prospect (2012-2022)
1.4.6 The South Veterinary Anti-infectives Status and Prospect (2012-2022)
1.4.7 The Midwest Veterinary Anti-infectives Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Veterinary Anti-infectives (2012-2022)
1.5.1 United States Veterinary Anti-infectives Sales and Growth Rate (2012-2022)
1.5.2 United States Veterinary Anti-infectives Revenue and Growth Rate (2012-2022)

2 United States Veterinary Anti-infectives Market Competition by Players/Suppliers
2.1 United States Veterinary Anti-infectives Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Veterinary Anti-infectives Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Veterinary Anti-infectives Average Price by Players/Suppliers (2012-2017)
2.4 United States Veterinary Anti-infectives Market Competitive Situation and Trends
2.4.1 United States Veterinary Anti-infectives Market Concentration Rate
2.4.2 United States Veterinary Anti-infectives Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Veterinary Anti-infectives Manufacturing Base Distribution, Sales Area, Product Type

3 United States Veterinary Anti-infectives Sales (Volume) and Revenue (Value) by Region (2012-2017)
3.1 United States Veterinary Anti-infectives Sales and Market Share by Region (2012-2017)
3.2 United States Veterinary Anti-infectives Revenue and Market Share by Region (2012-2017)
3.3 United States Veterinary Anti-infectives Price by Region (2012-2017)

4 United States Veterinary Anti-infectives Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
4.1 United States Veterinary Anti-infectives Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Veterinary Anti-infectives Revenue and Market Share by Type (2012-2017)
4.3 United States Veterinary Anti-infectives Price by Type (2012-2017)
4.4 United States Veterinary Anti-infectives Sales Growth Rate by Type (2012-2017)

5 United States Veterinary Anti-infectives Sales (Volume) by Application (2012-2017)
5.1 United States Veterinary Anti-infectives Sales and Market Share by Application (2012-2017)
5.2 United States Veterinary Anti-infectives Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States Veterinary Anti-infectives Players/Suppliers Profiles and Sales Data
6.1 Zoetis Animal Healthcare
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Veterinary Anti-infectives Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Zoetis Animal Healthcare Veterinary Anti-infectives Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Merck
6.2.2 Veterinary Anti-infectives Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Merck Veterinary Anti-infectives Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Merial (Sanofi)
6.3.2 Veterinary Anti-infectives Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Merial (Sanofi) Veterinary Anti-infectives Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Elanco
6.4.2 Veterinary Anti-infectives Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Elanco Veterinary Anti-infectives Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Bayer Healthcare
6.5.2 Veterinary Anti-infectives Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Bayer Healthcare Veterinary Anti-infectives Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Ceva Animal Health
6.6.2 Veterinary Anti-infectives Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Ceva Animal Health Veterinary Anti-infectives Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Virbac
6.7.2 Veterinary Anti-infectives Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Virbac Veterinary Anti-infectives Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Boehringer Ingelheim
6.8.2 Veterinary Anti-infectives Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Boehringer Ingelheim Veterinary Anti-infectives Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview

7 Veterinary Anti-infectives Manufacturing Cost Analysis
7.1 Veterinary Anti-infectives Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Veterinary Anti-infectives

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Veterinary Anti-infectives Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Veterinary Anti-infectives Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Veterinary Anti-infectives Market Size (Value and Volume) Forecast (2017-2022)
11.1 United States Veterinary Anti-infectives Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Veterinary Anti-infectives Sales Volume Forecast by Type (2017-2022)
11.3 United States Veterinary Anti-infectives Sales Volume Forecast by Application (2017-2022)
11.4 United States Veterinary Anti-infectives Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer


Back To Top